Seattle’s Alpine Immune Sciences licenses cancer treatment to Kite Pharma for up to $530M by Jacob Demmitt on October 27, 2015October 27, 2015 at 3:37 pm Seattle-based immunotherapy startup Alpine Immune Sciences has signed an exclusive licensing deal with Kite Pharma that could be worth as much as $530 million if the startup’s cancer-fighting treatments pan out.… Read More